Our site uses cookies to make navigation as function as possible, including “third party” cookies and “profiling cookies” designed to tailor
on-line contents to suit the preferences expressed while surfing the internet. Should you wish to receive more information, or deny your
consent to some or all cookies, click here. If you proceed with browsing this website, you will be consenting to the use of all cookies.

美纳里尼基金会

该基金会成立于 1976 年...

GO TO SITE

美纳里尼在亚太地区

搜索我们的公司

主要品牌

最新动态

September 21 2023

European Commission Approves Menarini Group’s ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

Read More
September 13 2023

美纳里尼亚太与安斯泰来签订独家授权协议在中国台湾和部分东南亚市场商业化施觅福®

Read More
July 21 2023

Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation

Read More
July 06 2023

Fair Play Menarini International Awards, the 2023 edition starts with the talk show “The Champions tell their Stories” in Piazza della Signoria, Florence

Read More
June 26 2023

美纳里尼第二代抗组胺药力敏能®(比拉斯汀片)在中国获批,引领荨麻疹高品质诊疗新时代

Read More